Skip to main content
OpenTrials
Completed

NCT Number: NCT03837119

Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies

This retrospective study aims to investigate pregnancy outcome in women with heterozygous hemoglobinopathies (regarding gestational diabetes, cholestasis and urinary tract infections) and to analyze if there are aggravated maternal and/or perinatal risks.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Frauenklinik University Hospital Basel, Basel, Switzerland

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pregnant women with or without heterozygous hemoglobinopathy

Exclusion criteria

  • refusal of study participation

Treatment and study plan

pregnancy outcome

Other

descriptive statistics of variables

Primary outcomes

  1. gestational diabetes

    Time frame: in the course of pregnancy until delivery

    number of women developing gestational diabetes in pregnancy

  2. cholestasis in pregnancy

    Time frame: in the course of pregnancy until delivery

    number of women developing cholestasis in pregnancy

  3. urinary tract infection

    Time frame: in the course of pregnancy until delivery

    number of women developing urinary tract infection

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Feb 11, 2019
Registry last updated
Dec 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.